Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Avidity Biosciences, Inc. | Chief Financial Officer | Common Stock | 121K | $5.34M | $44.00 | Sep 19, 2024 | Direct |
Verve Therapeutics, Inc. | Director | Stock Option (right to buy) | 136K | Jun 26, 2024 | Direct | ||
Avidity Biosciences, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 65.2K | Jun 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNA | Avidity Biosciences, Inc. | Sep 19, 2024 | 3 | -$506K | 4 | Sep 23, 2024 | Chief Financial Officer |
VERV | Verve Therapeutics, Inc. | Jun 26, 2024 | 1 | $0 | 4 | Jun 28, 2024 | Director |
RNA | Avidity Biosciences, Inc. | Jun 17, 2024 | 3 | -$439K | 4 | Jun 20, 2024 | Chief Financial Officer |
RNA | Avidity Biosciences, Inc. | Jun 12, 2024 | 3 | -$2.8M | 4 | Jun 14, 2024 | Chief Financial Officer |
RNA | Avidity Biosciences, Inc. | May 14, 2024 | 3 | -$1.46M | 4 | May 16, 2024 | Chief Financial Officer |
RNA | Avidity Biosciences, Inc. | Mar 13, 2024 | 3 | -$628K | 4 | Mar 15, 2024 | Chief Financial Officer |
RNA | Avidity Biosciences, Inc. | Jan 20, 2024 | 3 | -$16.4K | 4 | Jan 23, 2024 | Chief Financial Officer |
RNA | Avidity Biosciences, Inc. | Sep 11, 2023 | 1 | $0 | 4 | Sep 12, 2023 | Chief Financial Officer |
VERV | Verve Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
VERV | Verve Therapeutics, Inc. | Feb 14, 2023 | 1 | $0 | 4 | Feb 16, 2023 | Director |
RNA | Avidity Biosciences, Inc. | Jan 20, 2023 | 2 | $0 | 4 | Jan 24, 2023 | Chief Financial Officer |
VERV | Verve Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
RNA | Avidity Biosciences, Inc. | Jan 21, 2022 | 1 | $0 | 4 | Mar 15, 2022 | Chief Financial Officer |
VERV | Verve Therapeutics, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
VERV | Verve Therapeutics, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | Director |